Fig. 10From: Construction and validation of a cuproptosis-related five-lncRNA signature for predicting prognosis, immune response and drug sensitivity in breast cancerTumor Mutation Genes and Burden in Diferent Risk Groups Based on Signature. A,B Detailed mutation information for each gene in the high and low risk group; C The survival outcomes combination of patients in the high-low mutation burden group with the high and low risk groupBack to article page